School of Engineering
Showing 121-130 of 954 Results
-
Edward Y. Chang
Adjunct Professor, Computer Science
BioEdward Y. Chang has been an adjunct professor in Stanford’s Computer Science Department since 2019. Previously, he was a tenured professor at UC Santa Barbara. From 2006 to 2012, he served as a director at Google Research, where he pioneered data-centric and parallel machine learning and contributed to the ImageNet project. Chang later became president of HTC Healthcare, where he developed AI-powered diagnostics and won the Tricorder XPRIZE. He has also held positions at HKUST and UC Berkeley. Chang earned an MS in Computer Science and a PhD in Electrical Engineering from Stanford. He is a Fellow of ACM and IEEE for his contributions to scalable machine learning and healthcare AI.
Since 2019, Chang’s research has focused on virtual assistance, collaborating with Monica Lam, and more recently on large language models (LLMs). He hypothesizes that LLM Collaborative Intelligence (LCI) could pave the way toward artificial general intelligence (AGI).
Chang has authored seven books, including:
Unlocking the Wisdom of Large Language Models (2024)
LLM Collaborative Intelligence: The Path to Artificial General Intelligence (2024)
Journey of the Mind (Poetry, 2023)
Mandarin translation of Erwin Schrödinger’s What is Life? Mind and Matter (2021)
Big Data Analytics for Large-Scale Multimedia Search (2019)
Nomadic Eternity (Poetry, 2012)
Foundations of Large-Scale Multimedia Information Management and Retrieval (2011) -
Ying Chih Chang
Adjunct Professor, Chemical Engineering
BioDr. Ying Chang is the Chair of the Taiwan Science and Technology Hub and an Adjunct Professor in the Department of Chemical Engineering at Stanford University. She is also the Founder and CEO of Acrocyte Therapeutics, Inc.
Her former faculty appointments include Research Fellow (-Associate Fellow) at the Genomics Research Center, Academia Sinica, Taiwan, and Assistant Professor in the Departments of Chemical Engineering and Materials Science, and Biomedical Engineering at the University of California, Irvine. The research highlights include integrating nanomaterials, microfluidics, and bioreactors to control cell fates for tissue engineering, as well as developing circulating tumor cell 3D culture for cancer diagnostics and precision medicine. She holds multiple patents in DNA microarray constructs (assigned to Affymetrix), circulating tumor cell isolation and cancer screening (assigned to Cellmax Life Inc.), and single cell derived scaffold free 3D culture platform RCE and circulating tumor cell liquid biopsy drug test (assigned to Acrocyte Therapeutics Inc. www.acrocyte.com).
Dr. Chang’s work was recognized by the Young Investigator Award from the Whitaker Foundation, FDA breakthrough device designation for pre-cancer and cancer detection (2021), Future Tech Award (2021), 18th National Innovation Award, Taiwan (2021), and Finalist at Startup Stadium at BIO 2024, among other. She is also on the board of trustees of Kaohsiaung Medical University, and Chang Chau-Ting Memorial Foundation, a non-profit organization for science education and awareness in Taiwan. She received her BS from National Taiwan University, and PhD from Stanford University, both in Chemical Engineering.
